Firearm violence is an ever-present concern, and Black Americans are disproportionately subjected to it. How does this impact the clinicians caring for victims, who must deal with the trauma and injustice daily? More
From approval to withdrawal, the story of Makena shows some of the major pitfalls of the FDA's drug approval process. More
The approval of Alzheimer's drug Aduhelm through the accelerated pathway has brought new attention to needed improvements to this process. More
The FDA approved Alzheimer's drug Aduhelm for all people with mild dementia -- but most of this population is at an increased risk of side effects from the drug. More
The FDA's approval of a new Alzheimer's treatment has significant implications for future drug trials, health system costs, patient safety, and conflicts of interest. More
How is the FDA measuring success when it comes to approval for new cancer drugs? More
Can we trust drug companies to monitor and regulate the safety of their own products? More
Is the FDA's accelerated approval program resulting in better cancer drugs? Two new studies provide insight... More
Do FDA rules make it too difficult for new diagnostic tests to be approved? Or is it too easy? More